These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 27105509)
1. Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells. Li X; Chen F; Zhu Q; Ding B; Zhong Q; Huang K; Jiang X; Wang Z; Yin C; Zhu Y; Li Z; Meng F Oncotarget; 2016 May; 7(22):33004-15. PubMed ID: 27105509 [TBL] [Abstract][Full Text] [Related]
2. Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells. Liang H; Zheng QL; Fang P; Zhang J; Zhang T; Liu W; Guo M; Robinson CL; Chen SB; Chen XP; Chen FP; Zeng H Sci Rep; 2017 Jan; 7():40361. PubMed ID: 28098170 [TBL] [Abstract][Full Text] [Related]
3. GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia. Zhou C; Du J; Zhao L; Liu W; Zhao T; Liang H; Fang P; Zhang K; Zeng H Cell Death Dis; 2021 Mar; 12(3):231. PubMed ID: 33658491 [TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023 [TBL] [Abstract][Full Text] [Related]
5. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma. Yang Z; Zhang C; Qi W; Cui Y; Xuan Y Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514 [TBL] [Abstract][Full Text] [Related]
6. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo. Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling. Yang X; Ding Y; Xiao M; Liu X; Ruan J; Xue P Chem Biol Interact; 2017 Dec; 278():22-31. PubMed ID: 28987325 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells. D'Amato C; Rosa R; Marciano R; D'Amato V; Formisano L; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fulciniti F; Cipolletta A; Bianco C; Ciardiello F; Veneziani BM; De Placido S; Bianco R Br J Cancer; 2014 Sep; 111(6):1168-79. PubMed ID: 25093491 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells. Li Y; Guo Y; Feng Z; Bergan R; Li B; Qin Y; Zhao L; Zhang Z; Shi M Nutr Cancer; 2019; 71(6):1007-1018. PubMed ID: 31032633 [TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells. Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564 [TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia. Latuske EM; Stamm H; Klokow M; Vohwinkel G; Muschhammer J; Bokemeyer C; Jücker M; Kebenko M; Fiedler W; Wellbrock J Oncotarget; 2017 Apr; 8(17):29187-29201. PubMed ID: 28418873 [TBL] [Abstract][Full Text] [Related]
12. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells. Davoudi Z; Akbarzadeh A; Rahmatiyamchi M; Movassaghpour AA; Alipour M; Nejati-Koshki K; Sadeghi Z; Dariushnejad H; Zarghami N Asian Pac J Cancer Prev; 2014; 15(10):4353-8. PubMed ID: 24935396 [TBL] [Abstract][Full Text] [Related]
14. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis. Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464 [TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of Glioma-Associated Oncogene Homolog 1 Expression by Serum Starvation Promotes Cell Survival in ER-Positive Breast Cancer Cells. Xu J; Huang G; Zhang Z; Zhao J; Zhang M; Wang Y; Liu Z; Lu J Cell Physiol Biochem; 2015; 36(5):1862-76. PubMed ID: 26182949 [TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. Zhang Y; Liu Y; Xu X J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500 [TBL] [Abstract][Full Text] [Related]
18. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells. Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia. Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434 [TBL] [Abstract][Full Text] [Related]
20. Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia. Huang K; Sun Z; Ding B; Jiang X; Wang Z; Zhu Y; Meng F Onco Targets Ther; 2019; 12():7477-7488. PubMed ID: 31686853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]